Home/Pipeline/SCO-272

SCO-272

Diabetic kidney disease, Hypertension

PreclinicalActive

Key Facts

Indication
Diabetic kidney disease, Hypertension
Phase
Preclinical
Status
Active
Company

About SCOHIA PHARMA

A Japanese bioventure developing innovative small molecule drugs for metabolic, cardiovascular, and renal diseases through a diversified pipeline and strategic collaborations.

View full company profile